Alto Neuroscience, Inc.
Company Stats
- Market Cap
- $1.0B
- as of Sep 30, 2026
- Shares Outstanding
- 39.2M
- Free Float
- 84.1%
Income Statement
- Operating Income
- -$66.4M
- Net Income
- -$63.2M
- EBITDA
- -$65.7M
Cash Flow
- Free Cash Flow
- -$51.8M
- FCF Yield
- -5.2%
- Owner FCF Yield
- -6.0%
Balance Sheet
- Cash & Equivalents
- $176.5M
Returns & Capital
- SBC, 3Y Avg
- $6.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$51.8M | — |
| FY2024 | — | -$49.5M | — |
| FY2023 | — | -$33.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges